BioRestorative Therapies CEO Lance Alstodt's 2023 pay jumps 177% to $1.3M

BioRestorative Therapies reports 2023 executive compensation

By ExecPay News

Published: August 8, 2024

BioRestorative Therapies reported fiscal year 2023 executive compensation information on August 8, 2024.
In 2023, three executives at BioRestorative Therapies received on average a compensation package of $1M, a 192% increase compared to previous year.
Average pay of disclosed executives at BioRestorative Therapies
Lance Alstodt, Chief Executive Officer, received $1.3M in total, which increased by 177% compared to 2022. 38% of Alstodt's compensation, or $479K, was in salary. Alstodt also received $475K in bonus and $300K in option awards.
Francisco Silva, VP, Research and Development, received a compensation package of $1.2M, which increased by 182% compared to previous year. 38% of the compensation package, or $454K, was in salary.
Robert Kristal, Chief Financial Officer, earned $618K in 2023, a 253% increase compared to previous year.

Related executives

Lance Alstodt

BioRestorative Therapies

Chief Executive Officer

Francisco Silva

BioRestorative Therapies

VP, Research and Development

Robert Kristal

BioRestorative Therapies

Chief Financial Officer

You may also like

Source: SEC filing on August 8, 2024.